GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.

NCT04838743 · clinicaltrials.gov ↗

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: IDegLira

Sponsor

Novo Nordisk A/S